Skip to main content
$6.84 -$0.04 (-0.6%)

04:00 PM EDT on 10/15/21

Sorrento Therapeutics, Inc. (NASDAQ:SRNE)

CAPS Rating: 2 out of 5

Current Price $6.84 Mkt Cap $2.0B
Open $6.94 P/E Ratio 0.00
Prev. Close $6.84 Div. (Yield) $0.00 (0.0%)
Daily Range $6.79 - $7.02 Volume 3,706,881
52-Wk Range $5.17 - $17.25 Avg. Daily Vol. 4,858,790

Caps

How do you think NASDAQ:SRNE will perform against the market?

Add Stock to CAPS Watchlist

All Players

61 Outperform
17 Underperform
 

All-Star Players

12 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SRNE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Weidmans (80.89)
Submitted August 06, 2020

Covid test on track. With FDA and Approval and some government money, SRNE will be ready to fly!

TMFBiologyFool (67.20)
Submitted September 30, 2020

Many programs to treat/prevent/test for COVID-19, but very little progress on any of them.

NASDAQ:SRNE VS S&P 500 (SPY)

NASDAQ:SRNE Summary

Fools bullish on NASDAQ:SRNE are also bullish on:

Fools bearish on NASDAQ:SRNE are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SRNE.

Recs

0
Member Avatar RES7 (82.77) Submitted: 1/6/2021 9:49:26 PM : Underperform Start Price: $7.12 NASDAQ:SRNE Score: +21.65

Viceroy research

Recs

1
Member Avatar TMFBiologyFool (67.20) Submitted: 9/30/2020 12:52:56 PM : Underperform Start Price: $11.12 NASDAQ:SRNE Score: +70.20

Many programs to treat/prevent/test for COVID-19, but very little progress on any of them.

Recs

1
Member Avatar Weidmans (80.89) Submitted: 8/6/2020 1:59:17 PM : Outperform Start Price: $13.55 NASDAQ:SRNE Score: -82.57

Covid test on track. With FDA and Approval and some government money, SRNE will be ready to fly!

Leaderboard

Find the members with the highest scoring picks in SRNE.

Score Leader

Under5

Under5 (69.87) Score: +219.00

The Score Leader is the player with the highest score across all their picks in SRNE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Under5 69.87 10/18/2019 Outperform 5Y $1.71 +303.22% +49.20% +254.01 0 Comment
Bigsef77 69.82 5/11/2017 11/27/2020 Outperform 5Y $1.80 +283.06% +86.26% +196.79 1 Comment
OptimistPrime2 58.65 3/10/2015 Underperform 5Y $13.36 -48.39% +115.60% +163.99 0 Comment
MMCapitalMgmt 99.94 12/22/2014 Underperform 5Y $8.60 -19.83% +115.55% +135.38 0 Comment
EvanBuck 99.86 12/18/2014 Underperform 5Y $8.22 -16.12% +116.96% +133.08 0 Comment
Bobby2207 < 20 4/13/2020 Outperform 5Y $2.55 +170.39% +60.81% +109.59 0 Comment
Biotoday 68.05 11/26/2019 10/31/2020 Outperform 1Y $2.87 +140.24% +42.00% +98.24 0 Comment
amirite < 20 11/2/2017 Outperform 5Y $2.60 +165.19% +73.13% +92.06 0 Comment
TMFGBudwell 68.20 12/3/2019 Outperform 5Y $2.97 +132.15% +44.54% +87.62 0 Comment
TMFBiologyFool 67.20 9/30/2020 Underperform 1Y $11.12 -37.99% +32.21% +70.20 3 Comments

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SRNE.